Loading fund overlap…
23 of 161 unique stocks in common · Jaccard: 14.3%
A weighted portfolio overlap of 35.55% indicates a moderate overlap (a meaningful shared core). This means that out of every ₹100 you invest across these two schemes, approximately ₹35.55 is allocated to the exact same companies at the same relative proportions. The schemes share 23 common holdings.
The largest overlapping asset in their portfolios is HDFC Bank, which commands a weight of 5.18% in HDFC Dividend Yield Fund and 6.15% in Nippon India Retirement Fund - Wealth Creation Scheme. Holding both schemes increases your concentration in HDFC Bank rather than expanding your diversification.
If the overlap is above 30%, it is typically because both schemes benchmark to the same index (e.g. Nifty 50 or Nifty LargeMidcap 250) or overlap in their top large-cap picks. To improve your portfolio's diversification, consider allocating one of these tranches to a category with lower structural correlation (such as a mid-cap, small-cap, or international equity fund).
| Stock | in HDFC | in Nippon |
|---|---|---|
| HDFC BankBanks | 5.18% | 6.15% |
| ICICI BankBanks | 4.80% | 7.44% |
| Axis BankBanks | 3.74% | 3.63% |
| Larsen & ToubroConstruction | 2.69% | 3.20% |
| Reliance IndustriesPetroleum Products | 2.35% | 6.64% |
| NTPCPower | 2.00% | 2.47% |
| State Bank of IndiaBanks | 1.89% | 2.67% |
| InfosysIT - Software | 1.72% | 2.30% |
| Tata Consultancy ServicesIT - Software | 1.33% | 3.62% |
| Hindustan UnileverDiversified FMCG | 1.09% | 1.80% |
| SBI Life Insurance CompanyInsurance | 1.96% | 1.05% |
| Cummins IndiaIndustrial Products | 0.99% | 1.07% |
| Apollo Hospitals EnterpriseHealthcare Services | 0.98% | 1.06% |
| Power Finance CorporationFinance | 0.92% | 1.32% |
| PVR INOXEntertainment | 0.91% | 0.99% |
| Hindustan AeronauticsAerospace & Defense | 0.73% | 1.15% |
| GAIL (India)Gas | 0.59% | 1.01% |
| BoschAuto Components | 0.52% | 3.61% |
| Kaynes Technology IndiaIndustrial Manufacturing | 0.50% | 2.59% |
| Indraprastha GasGas | 0.46% | 0.99% |
| Bajaj FinservFinance | 0.48% | 0.42% |
| Gland PharmaPharmaceuticals & Biotechnology | 0.40% | 1.00% |
| LupinPharmaceuticals & Biotechnology | 0.40% | 0.69% |
Weighted overlap = Σ min(weight in fund A, weight in fund B) across shared stocks, from each fund's latest public monthly portfolio (as on May 2026). Equity holdings only, ISIN-verified. Not investment advice.